Gail Marcus

Gail Marcus is a dynamic senior executive, with experience in the public and private sectors. She has held leadership positions in Fortune 100 healthcare companies including various roles of increasing seniority with CIGNA, AdvancePCS/Caremark CVS, United Health Group, Susan G. Komen for the Cure, Calloway Laboratories, and Caris Diagnostics where she was CEO and President. Previously, Ms. Marcus was recognized as one of the Top 100 Women Leaders in Massachusetts by the Commonwealth Institute. Ms. Marcus currently serves on the boards of Biomodal, Cyted, and Natera (Nasdaq: NTRA), as board chair (Biomodal and Cyted), and board member (Natera). Additionally, she is an Assistant Professor of Population Health at Hofstra University. Gail earned her BA magna cum laude from Wesleyan University, an MSE from University of Pennsylvania Moore School of Engineering, an MBA from University of Pennsylvania, Wharton School and a DHA with honors from Medical University of South Carolina.